Literature DB >> 12712446

Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancer.

Noriaki Kitamura1, Shanchun Guo, Takeshi Sato, Sen Hiraizumi, Junko Taka, Masahiko Ikekita, Shuzo Sawada, Hirosuke Fujisawa, Kiyoshi Furukawa.   

Abstract

Our previous studies showed that expression of the GalNAcbeta1-->4GlcNAc group on N-linked oligosaccharides is associated with functional differentiation of the bovine mammary gland. In the present study, the occurrence of the GalNAcbeta1-->4GlcNAc group was established in human milk proteins and membrane glycoproteins from a human breast cancer cell line, MRK-nu-1, by structural analysis of oligosaccharides released by hydrazinolysis. Whether the expression level of the disaccharide group is affected upon malignant transformation was examined in human breast cancer specimens using Wistaria floribunda agglutinin (WFA) which interacts with oligosaccharides with N-acetylgalactosamine at their termini. Lectin blot analysis of membrane glycoprotein samples from human breast cancer specimens showed that the number of protein bands reacting with WFA, as well as their intensities, are lower in samples from primary carcinoma lesions compared with samples from surrounding normal tissues. No lectin binding was observed when the blots were treated with jack bean beta-N-acetylhexosaminidase or N-glycanase, indicating that WFA-reactive oligosaccharides are N-linked. A histochemical study of tissue specimens from 92 patients with breast cancer revealed that the reduced WFA staining levels in primary carcinoma lesions correlate with advancing clinical stages and prognostic status (i.e., 58% of patients in a group showing reduced/negative staining died of disease recurrence, whereas more than 90% of those in the positive staining group survived for 5 years after surgery). These results indicate that reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides on primary carcinoma lesions predicts a poor prognosis for patients with breast cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712446     DOI: 10.1002/ijc.11115

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Systems glycomics of adult zebrafish identifies organ-specific sialylation and glycosylation patterns.

Authors:  Nao Yamakawa; Jorick Vanbeselaere; Lan-Yi Chang; Shin-Yi Yu; Lucie Ducrocq; Anne Harduin-Lepers; Junichi Kurata; Kiyoko F Aoki-Kinoshita; Chihiro Sato; Kay-Hooi Khoo; Ken Kitajima; Yann Guerardel
Journal:  Nat Commun       Date:  2018-11-07       Impact factor: 14.919

2.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2020-01       Impact factor: 4.304

3.  LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.

Authors:  Kiyoko Hirano; Yoshio Takada; Kiyoshi Furukawa
Journal:  Histochem Cell Biol       Date:  2019-10-12       Impact factor: 4.304

4.  Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin.

Authors:  Omid Haji-Ghassemi; Michel Gilbert; Jenifer Spence; Melissa J Schur; Matthew J Parker; Meredith L Jenkins; John E Burke; Henk van Faassen; N Martin Young; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

5.  Wisteria floribunda agglutinin-binding glycan expression is decreased in endometriomata.

Authors:  Tomoko Hirakawa; Kaei Nasu; Kentaro Kai; Yoko Aoyagi; Terukazu Ishii; Tetsuya Uemura; Mitsutake Yano; Hisashi Narahara
Journal:  Reprod Biol Endocrinol       Date:  2014-10-24       Impact factor: 5.211

6.  Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Authors:  Kazuhisa Hagiwara; Yuki Tobisawa; Takatoshi Kaya; Tomonori Kaneko; Shingo Hatakeyama; Kazuyuki Mori; Yasuhiro Hashimoto; Takuya Koie; Yoshihiko Suda; Chikara Ohyama; Tohru Yoneyama
Journal:  Int J Mol Sci       Date:  2017-01-26       Impact factor: 5.923

7.  Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Authors:  Tohru Yoneyama; Yuki Tobisawa; Tomonori Kaneko; Takatoshi Kaya; Shingo Hatakeyama; Kazuyuki Mori; Mihoko Sutoh Yoneyama; Teppei Okubo; Koji Mitsuzuka; Wilhelmina Duivenvoorden; Jehonathan H Pinthus; Yasuhiro Hashimoto; Akihiro Ito; Takuya Koie; Yoshihiko Suda; Robert A Gardiner; Chikara Ohyama
Journal:  Cancer Sci       Date:  2019-06-27       Impact factor: 6.716

8.  Terminal N-acetylgalactosamine-specific leguminous lectin from Wisteria japonica as a probe for human lung squamous cell carcinoma.

Authors:  Keisuke Soga; Futaba Teruya; Hiroaki Tateno; Jun Hirabayashi; Kazuo Yamamoto
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 9.  Expression of LacdiNAc groups on N-glycans among human tumors is complex.

Authors:  Kiyoko Hirano; Akio Matsuda; Takashi Shirai; Kiyoshi Furukawa
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

10.  Lectins: an effective tool for screening of potential cancer biomarkers.

Authors:  Onn Haji Hashim; Jaime Jacqueline Jayapalan; Cheng-Siang Lee
Journal:  PeerJ       Date:  2017-09-07       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.